US Patent Issued to Janssen Biotech on May 20 for "EGFR and C-met fibronectin type III domain binding molecules" (Pennsylvania, Missouri, New Jersey Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,939, issued on May 20, was assigned to Janssen Biotech Inc. (Horsham, Pa.).

"EGFR and C-met fibronectin type III domain binding molecules" was invented by Mark Anderson (Norristown, Pa.), Ricardo Attar (Lawrence Township, N.J.), Michael Diem (Havertown, Pa.), Linus Hyun (King of Prussia, Pa.), Steven Jacobs (North Wales, Pa.), Alastair King (Lake Saint Louis, Mo.), Donna Klein (Philadelphia), Sheri Moores (Wayne, Pa.), Karyn O'Neil (Media, Pa.) and Kristen Picha (Malvern, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vecto...